Paul-Ehrlich-Institut Collected and Reported The Blood Supply Situation for 2024
Paul-Ehrlich-Institut shared a post on LinkedIn:
“Blood, blood products and stem cell preparations are indispensable for the treatment of many diseases and injuries. Their production relies on the help of numerous voluntary donors. It is therefore important to monitor the supply situation for blood and blood products in Germany so that measures can be taken to promote blood and plasma donation when shortages become apparent.
Every year, the Paul-Ehrlich-Institut collects data from donation centres, manufacturers and healthcare facilities in order to obtain a comprehensive overview of the supply of blood, blood products and stem cell preparations in Germany. The supply situation for 2024 is presented in the report that has now been published.
Read the full report here.”
Follow the latest in Hemostasis Today.
-
Sep 6, 2026, 18:17Aryabhatta Sadhu: Irradiation of Blood Components – From Clinical Indication to Laboratory Release
-
Sep 6, 2026, 18:15Ashenafi Tazebew Amare: A Year of Progress, Transformation and Renewed Commitment
-
Sep 6, 2026, 18:13Emilio Osorio: Can Anticoagulation Be Safely Discontinued After Surgical Left Atrial Appendage Occlusion?
-
Sep 6, 2026, 18:11Razan Alolyani: Our Research on Anticoagulation After Acute Ischemic Stroke Receives 2nd Place
-
Sep 6, 2026, 18:10Chayakrit Krittanawong: Have You Heard of Blood Clots in the Legs?
-
Sep 6, 2026, 18:08Trilok Chand: Microplastics Found in Human Testes and Blood Clots
-
Sep 6, 2026, 18:07Sarah Moharem Elgamal: Cardiovascular Imaging Beyond Anatomy Toward Earlier Risk Prediction
-
Sep 6, 2026, 16:41Christina P.: APS – How it Happens in Your Blood, the Warning Signs, and What to Do about It
-
Sep 6, 2026, 16:33Jose Angel Nicolas Avila: How Tissue Mitochondrial Activity Dictates Macrophage Pool Size